Company / Current Liabilities
Organon & Co. Current Liabilities History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$2.4B
FY2025
5-year range
$2.4B / $2.9B
FY2021-FY2025
Trend
-12.1%
vs FY2024
Sector context
#15 of 213
Health Care
What the data says
Among 213 Health Care companies, Organon & Co. is in the bottom 7% for current liabilities. Improved from $2.9B to $2.4B over the past 2 years.
Based on SEC 10-K filings.
$2.4B in FY2025 with a 5-year CAGR of -2.2%. Top quartile in the Health Care sector.
Improved from $2.9B to $2.4B over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- -1.6%
- 5-Year CAGR
- -2.2%
- 10-Year CAGR
- -
Sector benchmark
Bottom 7% in Health CareTop 93% of 213This company $2.4B Sector average $1.6B
▼
+50.5% above sector average
Key checks
Key Insights
- 5-year CAGR of -2.2%, indicating a declining trend.
- In FY2025, current liabilities decreased 12.1% year-over-year.
- Ranks #15 out of 213 companies in the Health Care sector.
- Peak current liabilities was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score 0.69 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
- Strong return on equity: 55.3%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.4B | -12.1% |
| FY2024 | $2.7B | -6.9% |
| FY2023 | $2.9B | +16.2% |
| FY2022 | $2.5B | -3.3% |
| FY2021 | $2.6B | -2.8% |
| FY2020 | $2.7B | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026